1. Feroz SH, Ahmed A, et al. Comparison of the efficacy of the various treatment modalities in the management of perianal Crohn’s fistula: A Review. Cureus. 2020;12(12):1-19. doi:10.7759/cureus.11882
2. Gecse KB, Bemelman W, et al. A global consensus on the classification, diagnosis, and multidisciplinary treatment of perianal fistuling Crohn’s disease. Gut. 2014;63:1381-1392. doi:10.1136/gutjnl-2013-306709.
3. Park JJ, Yang SK, et al. Second Korean guidelines for the management of Crohn’s disease. Intest Res. 2017;15(1):38-67. doi:10.5217/ir.2017.15.1.38.
4. Lee JL, Yoon YS, Yu CS. Treatment strategy for perianal fistulas in Crohn disease patients: The surgeon’s point of view. Ann Coloproctol. 2021;37(1):5-15. doi:10.3393/ac.2021.02.08.
5. Mahmoud NN, Halwani Y, et al. Current management of perineal Crohn’s disease. Current Problems in Surgery. 2017. doi:10.1067/j.cpsurg.2017.02.003.
6. Vogel JD, Johnson EK, et al. Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum. 2016;59(12):1117-1133. doi:10.1097/DCR.0000000000000733.
7. Hall JF, Bordeianou L, et al. Outcomes after operations for anal fistula: Results of a prospective, multicenter, regional study. Dis Colon Rectum. 2014;57(11):1304-1308. doi:10.1097/DCR.0000000000000216
8. Abramowitz L, Soudan D, et al. The outcome of fistulotomy for anal fistula at 1 year: A prospective multicentre French study. Colorectal Dis. 2016;18(3):279-285. doi:10.1111/codi.13121.
9. Marzo M, Felice C, et al. Management of perianal fistulas in Crohn’s disease: An up-to-date review. World J Gastroenterol. 2015;21(5):1394-1403. doi:10.3748/wjg.v21.i5.1394.
10. Thia KT, Mahadevan U, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009;15(1):17-24. doi:10.1002/ibd.20608.
11. West RL, Van der Woude CJ, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn’s disease with infliximab: A double-blind placebo-controlled study. Aliment Pharmacol Ther. 2004;20(11-12):1329-1336. doi:10.1111/j.1365-2036.2004.02247.x.
12. Dewint P, Hansen BE, et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: A randomised, double-blind, placebo controlled trial (ADAFI). Gut. 2014;63(2):292-299. doi:10.1136/gutjnl-2013-304488.
13. Panes J, Rimola J. Perianal fistulizing Crohn’s disease: Pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(11):652-664. doi:10.1038/nrgastro.2017.104.
14. Yassin NA, Askari A, et al. Systematic review: The combined surgical and medical treatment of fistulising perianal Crohn’s disease. Aliment Pharmacol Ther. 2014;40(7):741-749. doi:10.1111/apt.12906.